Westlin Corporation (WSTN) Peer Comparison
$10.21
As on 22-Oct-2026 09:48EDT
Market cap
$81 Mln
Revenue (TTM)
$0 Mln
P/E Ratio
68.1
P/B Ratio
0
Div. Yield
0 %
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
Market cap ($ Mln) |
81 | 5,246 | 3,346 | 10 | 2 |
Revenue ($ Mln) |
-- | 1,206 | 573 | 4 | 2 |
Net Profit ($ Mln) |
0.89 | 134.79 | 147.29 | -0.12 | -18.75 |
Net Margin (%) |
-- | 11.18 | 25.72 | 1.20 | -1,003.19 |
RoE (%) |
4.09 | 3.43 | 25.36 | 54.17 | -130.74 |
Price to Earnings |
68.07 | 40.24 | 23.88 | -- | -- |
Price-To-Book |
-- | 1.19 | 5.41 | 1,802.81 | 0.52 |
Income Statement ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Operating Revenue
|
-- | -- | -- | 4.06 | -- |
|
Cost of Revenue
|
-- | -- | -- | 2.68 | -- |
|
Gross Profit
|
-- | -- | -- | 1.38 | -- |
|
Operating Expenses
|
0.37 | -- | -- | 1.50 | -- |
|
Operating Profit (EBIT)
|
-0.37 | -- | -- | -0.11 | -- |
|
Other Income
|
-- | -- | -- | -- | -- |
|
Profit before Tax
|
0.69 | -- | -- | -0.12 | -- |
|
Provision for Tax
|
-- | -- | -- | -- | -- |
|
Profit after Tax (Net Income)
|
0.89 | -- | -- | -0.12 | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Consolidated Profit
|
-- | -- | -- | -- | -- |
Liabilities ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
43.52 | -- | -- | -0.29 | -- |
|
Minority Interest
|
-- | -- | -- | -- | -- |
|
Non-Current Liabilities
|
1.78 | -- | -- | 0.35 | -- |
|
Current Liabilities
|
0.47 | -- | -- | 0.89 | -- |
|
Total Liabilities
|
59.20 | -- | -- | 0.95 | -- |
Assets ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
58.88 | -- | -- | 0.20 | -- |
|
Current Assets
|
0.32 | -- | -- | 0.75 | -- |
|
Total Assets
|
45.77 | -- | -- | 0.95 | -- |
|
Total Debt*
|
0.35 | -- | -- | 0.31 | -- |
|
Net Current Assets
|
-- | -- | -- | -- | -- |
Cashflow ($ Mln)
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
-0.26 | -- | -- | 0.51 | -- |
|
Cash Flow from Investing Activities
|
-44.78 | -- | -- | -- | -- |
|
Cash from Financing Activities
|
45.29 | -- | -- | -- | -- |
|
Net Cash Inflow / Outflow
|
-- | -- | -- | -- | -- |
Ratios
Profitability Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
ROCE (%)
|
4.06 | -- | -- | -121.54 | -- |
|
ROE (%)
|
4.09 | -- | -- | 54.17 | -- |
|
ROA (%)
|
3.00 | -- | -- | -14.89 | -- |
|
EBIT Margin (%)
|
-- | -- | -- | -- | -- |
|
Net Margin (%)
|
-- | -- | -- | -3.05 | -- |
|
Cash Profit Margin (%)
|
-- | -- | -- | -- | -- |
Growth Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-- | -- | -- | 0.98 | -- |
|
EBIT Growth (%)
|
-- | -- | -- | -- | -- |
|
Net Profit Growth (%)
|
12,552.05 | -- | -- | 56.32 | -- |
|
EPS Growth (%)
|
109.48 | -- | -- | -- | -- |
|
Book Value Growth (%)
|
-- | -- | -- | -- | -- |
Valuation Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Price / Earnings
|
91.27 | -- | -- | -- | -- |
|
Price / Book Value
|
1.87 | -- | -- | -- | -- |
|
Dividend Yield (%)
|
-- | -- | -- | -- | -- |
|
EV/EBITDA
|
-60.16 | -- | -- | -- | -- |
|
Market Cap ($ Cr)
|
-- | -- | -- | -- | -- |
Solvency Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.01 | -- | -- | -1.05 | -- |
|
Short term debt to equity ratio
|
0.01 | -- | -- | -0.34 | -- |
|
Current Ratio
|
0.68 | -- | -- | 0.84 | -- |
|
Quick Ratio
|
-- | -- | -- | -- | -- |
|
Interest Coverage
|
-- | -- | -- | -- | -- |
Operating Efficiency Ratios
| Westlin Corporation (WSTN) | Waystar Holding Corp. (WAY) | Life360, Inc. (LIF) | Morningstar US Mid Cap PR USD (MMCP) | Valion Bio Inc (VBIO) | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
-- | -- | -- | -- | -- |
|
Asset Turnover
|
-- | -- | -- | 4.89 | -- |
|
Receivable days
|
-- | -- | -- | -- | -- |
|
Inventory Days
|
-- | -- | -- | -- | -- |
|
Payable days
|
-- | -- | -- | 65.92 | -- |
|
Cash Conversion Cycle
|
-- | -- | -- | -- | -- |